These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16420396)

  • 1. A 9-year review of dystonia from a movement disorders clinic in Singapore.
    Jamora RD; Tan AK; Tan LC
    Eur J Neurol; 2006 Jan; 13(1):77-81. PubMed ID: 16420396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary dystonia in a botulinum toxin clinic: clinical characteristics, neuroanatomical substrate and comparison with idiopathic dystonia.
    Strader S; Rodnitzky RL; Gonzalez-Alegre P
    Parkinsonism Relat Disord; 2011 Dec; 17(10):749-52. PubMed ID: 21852177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset primary dystonia in Zhejiang province of China: a service-based epidemiological study.
    Wang L; Chen Y; Hu B; Hu X
    Neurol Sci; 2016 Jan; 37(1):111-116. PubMed ID: 26306696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological analysis of primary dystonia in Szczecin and Gdańsk regions].
    Potemkowski A; Sławek J; Stankiewicz J; Fabian A
    Neurol Neurochir Pol; 2003; 37 Suppl 5():231-9. PubMed ID: 15098351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal dystonia, with special reference to writer's cramp.
    Gordon NS
    Int J Clin Pract; 2005 Sep; 59(9):1088-90. PubMed ID: 16115186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary focal dystonia: descriptive study of 205 patients].
    Bartolomé FM; Fanjul S; Cantarero S; Hernández J; García Ruiz PJ
    Neurologia; 2003 Mar; 18(2):59-65. PubMed ID: 12610754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dystonias: what the practitioner needs to know].
    von Dengler R; Rollnik JD
    MMW Fortschr Med; 2004 Nov; 146(48):44-6. PubMed ID: 15625936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-compulsive symptoms in primary focal dystonia: a controlled study.
    Barahona-Corrêa B; Bugalho P; Guimarães J; Xavier M
    Mov Disord; 2011 Oct; 26(12):2274-8. PubMed ID: 21830232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of primary late-onset focal dystonia in the Belgrade population.
    Pekmezović T; Ivanović N; Svetel M; Nalić D; Smiljković T; Raicević R; Kostić VS
    Mov Disord; 2003 Nov; 18(11):1389-92. PubMed ID: 14639690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in patients with focal dystonia.
    Pekmezovic T; Svetel M; Ivanovic N; Dragasevic N; Petrovic I; Tepavcevic DK; Kostic VS
    Clin Neurol Neurosurg; 2009 Feb; 111(2):161-4. PubMed ID: 18995953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult-onset focal dystonias: presentation and treatment options.
    Esper GJ; Charles PD; Davis TL; Robertson D
    Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focal dystonia: clinical, etiologic and therapeutic aspects].
    Tranchant C
    Rev Neurol (Paris); 2000 Dec; 156(12):1087-94. PubMed ID: 11139724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic evaluation in a French population presenting with primary focal dystonia.
    Dhaenens CM; Krystkowiak P; Douay X; Charpentier P; Bele S; Destée A; Sablonnière B
    Mov Disord; 2005 Jul; 20(7):822-5. PubMed ID: 15726581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to assess motor impairment in writer's cramp.
    Zeuner KE; Peller M; Knutzen A; Holler I; Münchau A; Hallett M; Deuschl G; Siebner HR
    Mov Disord; 2007 Jun; 22(8):1102-9. PubMed ID: 17230462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of primary focal dystonias in the western area of Tottori prefecture in Japan: Comparison with prevalence evaluated in 1993.
    Fukuda H; Kusumi M; Nakashima K
    Mov Disord; 2006 Sep; 21(9):1503-6. PubMed ID: 16755586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of dystonia in Japan].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    Rinsho Shinkeigaku; 2005 Sep; 45(9):634-42. PubMed ID: 16248394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp.
    Delmaire C; Vidailhet M; Elbaz A; Bourdain F; Bleton JP; Sangla S; Meunier S; Terrier A; Lehéricy S
    Neurology; 2007 Jul; 69(4):376-80. PubMed ID: 17646630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.